Spero Therapeutics (SPRO) Total Non-Current Liabilities (2016 - 2023)
Spero Therapeutics (SPRO) reported Total Non-Current Liabilities of $48.87 million for Q4 2022, down 40.4% from $81.98 million a year earlier but up 53.2% from the prior quarter.
Powered by 
Analysis
Spero Therapeutics (SPRO) Total Non-Current Liabilities (2016 - 2023) Analysis & Trends
Dating back to Q4 2016, Spero Therapeutics' Total Non-Current Liabilities record includes 16 quarters.
- Total Non-Current Liabilities has a five-year compound annual growth rate of 43.1% (FY2017 to FY2022).
- By year, Total Non-Current Liabilities came in at $81.98 million in FY2021 and $12.32 million in FY2018 (+51.0%).
- Five-year quarterly Total Non-Current Liabilities spans a low of $5.83 million in Q1 2018 and a high of $82.36 million in Q1 2022.
- Per Business Quant data, the three quarters before Q4 2022 came in at $31.89 million (Q3 2022), $27.61 million (Q2 2022) and $82.36 million (Q1 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 60.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 102.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 117.60 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 79.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -36.84 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 76.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.05 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 96.04 Bn |
| 10 | Spero Therapeutics | 58.73 Mn | -137.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 75.50 Mn |
| Sep 30, 2023 | 53.40 Mn |
| Jun 30, 2023 | 44.10 Mn |
| Dec 31, 2022 | 48.87 Mn |
| Sep 30, 2022 | 31.89 Mn |
| Jun 30, 2022 | 27.61 Mn |
| Mar 31, 2022 | 82.36 Mn |
| Dec 31, 2021 | 81.98 Mn |
| Sep 30, 2021 | 32.80 Mn |
| Jun 30, 2021 | 29.34 Mn |
| Mar 31, 2020 | 27.27 Mn |
| Sep 30, 2019 | 19.28 Mn |
| Jun 30, 2019 | 12.62 Mn |
| Mar 31, 2019 | 11.10 Mn |
| Dec 31, 2018 | 12.32 Mn |
| Sep 30, 2018 | 10.28 Mn |
| Jun 30, 2018 | 6.60 Mn |
| Mar 31, 2018 | 5.83 Mn |
| Dec 31, 2017 | 8.16 Mn |
| Sep 30, 2017 | 113.35 Mn |
API Access
Spero Therapeutics Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SPRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "SPRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SPRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();